| Patient | Joe Frazier |
|---|---|
| Date of birth | 1944-01-12 |
| Identifiers | MRN HR-BX004-SYN-TD; SSN (made up) 000-04-5590 |
| Document date | 2008-03-02 |
| Author | Anjali Deshpande, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
High FIB-4 (3.43) with a mildly raised AST and low platelets at the yearly liver check in a 64-year-old man with type 2 diabetes, hypertension, low HDL, high triglycerides and obesity, who drinks little. Please stage his liver disease with elastography and advise on surveillance and treatment. [S]
Urgency: Within two weeks, with elastography and an ultrasound the same day. [S]
Questions for the consultant:
Mr. Frazier, a 64-year-old former professional boxer, is seen at the request of Dr. Whitfield for a FIB-4 of 3.43 found at his yearly diabetes check. He feels well and has had no jaundice, abdominal or leg swelling, black stools, vomiting of blood or confusion. He drinks one or two beers on some weekends and has never drunk heavily. He has had diabetes for about twelve years and high blood pressure for many years. He has never had a blood transfusion or used injected drugs. He wants to keep working at his gym. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
2 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Metformin 1000 mg oral tablet, one tablet twice daily with meals; taken for years | One tablet twice daily with meals | Oral route | 2008-02-16 | active | S |
| Lisinopril 20 mg oral tablet, one tablet daily; taken for years | One tablet daily | Oral route | 2008-02-16 | active | S |
| Atorvastatin 40 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2008-02-16 | active | S |
| Amlodipine 5 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2008-03-02 to 2008-04-13 | completed | S |
| Semaglutide pen (0.25 mg or 0.5 mg per dose), 0.25 mg under the skin once weekly for four weeks, then 0.5 mg once weekly | 0.25 mg weekly for four weeks, then 0.5 mg weekly | Subcutaneous route | 2008-03-02 to 2008-05-18 | completed | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Type 2 diabetes with hyperglycemia, about twelve years' duration, A1c 8.4% on metformin; synthetic modern episode linked to his publicly reported diabetes | active | confirmed | E11.65 | S — Synthetic modern diagnosis; diabetes was reported publicly during his life, but its duration and treatment here are synthetic. |
| Hypertension above goal on lisinopril (152/92 mmHg in the clinic); synthetic modern episode linked to his publicly reported high blood pressure | active | confirmed | I10 | S — Synthetic modern diagnosis; high blood pressure was reported publicly during his life. |
| Raised AST (48 U/L) with mildly low platelets (138) and a FIB-4 score of 3.43 at the yearly liver check, to be evaluated | resolved | confirmed | R74.01 | S — Synthetic presenting finding, superseded at the two-week visit by the elastography and ultrasound diagnosis. |
| Metabolic dysfunction-associated steatotic liver disease (MASLD): steatosis on elastography (controlled attenuation parameter 318 dB/m) and ultrasound, with diabetes, obesity, low HDL and high triglycerides, and little alcohol | active | confirmed | K76.0 | S — Synthetic modern diagnosis. Not part of the public record of his life; chosen to teach surveillance. |
| Compensated cirrhosis (compensated advanced chronic liver disease) from MASLD: liver stiffness 17.6 kPa, platelets 138, nodular liver surface and a spleen of 13.4 cm on ultrasound; no ascites, encephalopathy, bleeding or jaundice; Child-Pugh A | active | confirmed | K74.69 | S — Synthetic modern diagnosis. Not part of the public record of his life; the liver cancer diagnosed three years later in the true frame does not appear in the modern episode. |
| Hyperlipidemia: LDL 132 mg/dL, HDL 38 and triglycerides 210, not on a statin | active | confirmed | E78.5 | S — Synthetic laboratory finding. |
| Obesity, class 1 (BMI 31.4) | active | confirmed | E66.811 | S — Synthetic finding; described without stigma. |
| Reduced vision in the left eye since a cataract found at 20 (counting fingers at 1 meter); right eye 20/30 | active | confirmed | H54.62 | S — Synthetic modern measurement anchored to the documented cataract in his left eye. |
Vital signs recorded on 2008-03-02; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 148/90, pulse 74; BMI 31.3 |
| Abdomen | Liver edge firm at the costal margin; spleen tip not felt; no ascites |
| Skin | No jaundice, spider angiomas or palmar erythema |
| Neurological | No asterixis |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2008-03-02 | Liver stiffness by US.transient elastography | 17.6 | kPa | Below 8 kPa makes advanced fibrosis unlikely; 15 kPa or higher is consistent with compensated advanced chronic liver disease | High | S |
| 2008-03-02 | INR in Platelet poor plasma by Coagulation assay | 1.1 | {INR} | 0.8-1.2 | Normal | S |
| 2008-03-02 | Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma | 4.2 | ng/mL | <=8.3 ng/mL | Normal | S |
Data reviewed: Dr. Whitfield's intake note and results: AST 48, ALT 42 U/L, alkaline phosphatase 96, albumin 4.0 g/dL, bilirubin 0.9 mg/dL, platelets 138, creatinine 1.08 mg/dL, FIB-4 3.43. Today: transient elastography with a median liver stiffness of 17.6 kPa (interquartile range 14%) and a controlled attenuation parameter of 318 dB/m; ultrasound with a coarse, echogenic, mildly nodular liver, a spleen of 13.4 cm, a patent portal vein, no ascites and no focal lesion; INR 1.1; AFP 4.2 ng/mL. Hepatitis B surface antigen, core antibody and surface antibody negative; hepatitis A antibody negative; hepatitis C antibody and HIV nonreactive; ferritin and transferrin saturation normal; antinuclear and smooth muscle antibodies negative. [S]